Meet our Project Partner: Italian Institute for Privacy and Data Valorisation (IIP)
- Dimitris Petkousis
- Oct 12
- 2 min read
The Italian Institute for Privacy and Data Valorisation (IIP) assumes responsibility within the INSAFEDARE project for ensuring the lawful and ethically sound utilisation of health data. In particular, the Institute verifies that both real and synthetic datasets employed for regulatory purposes are processed in strict conformity with the General Data Protection Regulation (GDPR), the guiding principles of the Artificial Intelligence Act, and the broader acquis concerning the safeguarding of fundamental rights. The Institute further contributes by providing specialist guidance on the operationalisation of privacy by design, the fulfilment of accountability obligations, and the structuring of ethical governance frameworks, thereby securing the necessary integration between technological development and binding regulatory requirements.
In the course of the last quarter, the Institute has advanced its mission through a combination of research, dissemination, and active participation in key scientific and policy fora.
It has co-authored a study dedicated to the FAIR assessment framework for digital health devices, presented original work on the role of synthetic data in regulatory decision-making, and published a poster examining the integration of synthetic data into mobile health applications within the framework of the European Health Data Space.
In addition, the Institute has also published a scholarly article addressing ethical artificial intelligence, risk management, and data protection in the context of technological innovation, while further manuscripts devoted to the regulation of synthetic data and the deployment of privacy-enhancing technologies are currently being finalised.
During the same period, the Institute has contributed its expertise at international conferences such as ICIMTH 2024 and MIE 2024. Looking ahead to 2025, it has already scheduled a series of seminars devoted to the NIS2 Directive, the Digital Operational Resilience Act (DORA), and governance structures relating to synthetic data. All the foregoing premises considered, dissemination and communication activities have been pursued through posters, conference presentations, and targeted networking within the European policy communities concerned with health and artificial intelligence, thereby ensuring both the visibility and the influence of the Institute’s work within the wider regulatory and scientific debate.





Comments